ntravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Published in:

Health Technology Assessment, 2021, v. 25, n. 38, p. vii, doi. 10.3310/hta25380

By:

• Hykin, Philip;
• Prevost, A. Toby;
• Sivaprasad, Sobha;
• Vasconcelos, Joana C.;
• Murphy, Caroline;
• Kelly, Joanna;
• Ramu, Jayashree;
• Alshreef, Abualbishr;
• Flight, Laura;
• Pennington, Rebekah;
• Hounsome, Barry;
• Lever, Ellen;
• Metry, Andrew;
• Poku, Edith;
• Yang, Yit;
• Harding, Simon P.;
• Lotery, Andrew;
• Chakravarthy, Usha;
• Brazier, John

Publication type:

Article